drugset / Trial / NCT01604746
Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to verify the long-term safety of a 2.5 µg, adjuvanted (aluminium hydroxide) dose of Ross River Virus (RRV) vaccine.
Timeline
- Start
- 2012-07
- Primary completion
- 2013-04
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ross River Virus (RRV) Vaccine | Vaccine | 2.5 ug | — |